Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
| Index | MSCI ACWI IMI Innovation Select Screened 200 |
| Investment focus | Equity, World, Social/Environmental |
| Fund size | EUR 6 m |
| Total expense ratio | 0.30% p.a. |
| Replication | Physical (Full replication) |
| Legal structure | ETF |
| Strategy risk | Long-only |
| Sustainability | Yes |
| Fund currency | USD |
| Currency risk | Currency unhedged |
| Volatility 1 year (in EUR) | 19.38% |
| Inception/ Listing Date | 12 July 2022 |
| Distribution policy | Accumulating |
| Distribution frequency | - |
| Fund domicile | Ireland |
| Fund Provider | Xtrackers |
| Fund Structure | Open-ended Investment Company (OEIC) |
| UCITS compliance | Yes |
| Administrator | State Street Custodial Services (Ireland) Limited |
| Investment Advisor | DWS Investments UK Limited |
| Custodian Bank | State Street Custodial Services (Ireland) Limited, Dublin 2 |
| Revision Company | Pricewaterhouse Coopers |
| Fiscal Year End | 31 December |
| Swiss representative | DWS CH AG |
| Swiss paying agent | Deutsche Bank (Suisse) SA |
| Germany | 30% tax rebate |
| Switzerland | ESTV Reporting |
| Austria | Tax Reporting Fund |
| UK | UK Reporting |
| Indextype | - |
| Swap counterparty | - |
| Collateral manager | |
| Securities lending | Yes |
| Securities lending counterparty |
| Tesla | 4.86% |
| Roche Holding | 4.75% |
| Vertex Pharmaceuticals | 4.75% |
| Visa | 4.68% |
| Mastercard | 4.65% |
| Apple | 4.64% |
| Microsoft | 4.26% |
| NVIDIA | 4.12% |
| Alphabet, Inc. A | 2.67% |
| Amazon com | 2.59% |
| Broker | Rating | Execution fee | Account fee | |
|---|---|---|---|---|
| 0.00€ | 0.00€ | View offer** | |
| 0.00€ | 0.00€ | View offer* | |
| 0.00€ | 0.00€ | View offer* | |
| 0.00€ | 0.00€ | View offer* | |
| 0.00€ | 0.00€ | View offer* |
| Broker | Rating | Order fee | ETF savings plans | |
|---|---|---|---|---|
| 0.00€ | 3043 | View offer** | |
| 0.00€ | 2617 | View offer* | |
| 0.00€ | 1870 | View offer* | |
| 1.00€ | 2636 | View offer* | |
| 0.00€ | 2280 | View offer* |
| YTD | -5.08% |
| 1 month | -6.41% |
| 3 months | -6.34% |
| 6 months | -0.86% |
| 1 year | -4.06% |
| 3 years | +46.02% |
| 5 years | - |
| Since inception (MAX) | +40.83% |
| 2025 | +1.39% |
| 2024 | +29.60% |
| 2023 | +27.60% |
| 2022 | - |
| Volatility 1 year | 19.38% |
| Volatility 3 years | 17.21% |
| Volatility 5 years | - |
| Return per risk 1 year | -0.21 |
| Return per risk 3 years | 0.78 |
| Return per risk 5 years | - |
| Maximum drawdown 1 year | -20.28% |
| Maximum drawdown 3 years | -24.16% |
| Maximum drawdown 5 years | - |
| Maximum drawdown since inception | -24.16% |
| Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| gettex | EUR | XNNV | - - | - - | - |
| Borsa Italiana | EUR | XNNV | XNNV IM XNNVEUIV | XNNV.MI XNNVEURINAV=SOLA | |
| London Stock Exchange | USD | XNNV | XNNV LN XNNVUSIV | XNNV.L XNNVUSDINAV=SOLA | |
| London Stock Exchange | GBP | XNNS | XNNS LN XNNVCHIV | XNNS.L XNNVCHFINAV=SOLA | |
| XETRA | EUR | XNNV | XNNV GR | XNNV.DE |
| Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
|---|---|---|---|---|
| iShares Healthcare Innovation UCITS ETF | 916 | 0.40% p.a. | Accumulating | Sampling |
| Amundi MSCI Disruptive Technology UCITS ETF Acc | 133 | 0.45% p.a. | Accumulating | Full replication |
| WisdomTree Megatrends UCITS ETF USD | 29 | 0.50% p.a. | Accumulating | Full replication |
| VanEck Genomics and Healthcare Innovators UCITS ETF A | 13 | 0.35% p.a. | Accumulating | Full replication |
| Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C | 6 | 0.30% p.a. | Accumulating | Full replication |